DeepMed Research

Cancer Hospital, Chinese Academy of Medical Sciences

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma

Phase 2

Completed

Conditions: Hepatocellular Carcinoma, Radiotherapy, Sorafenib

Interventions: Radiation: concurrent sorafenib and IMRT, followed sorafenib maintenance

First Posted Date: 2018-05-24

Last Posted Date: 2024-01-10

Lead Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Target Recruit Count: 86

Registration Number: NCT03535259

Locations: 🇨🇳
Bo Chen, Beijing, Beijing, China

A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal Cancer

Not Applicable

Conditions: Malignant Neoplasm of Supraglottis Primary
Neck Dislocation
Laryngeal Neoplasms

Interventions: Procedure: Bilateral Neck Dissection
Procedure: Unilateral Neck Dissection

First Posted Date: 2018-01-05

Last Posted Date: 2018-01-09

Lead Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Target Recruit Count: 308

Registration Number: NCT03392220

Locations: 🇨🇳
Cancer Hospital, Chinese Academy of Medical Science, Beijing, Beijing, China

Daytime Variation of Complication in Gastric and Pancreatic Surgery

Conditions: Hemorrhage
Gastrointestinal Dysfunction
Infection
Fistula

Interventions: Procedure: operation in different stages of the day

First Posted Date: 2017-12-26

Last Posted Date: 2017-12-26

Lead Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Target Recruit Count: 200

Registration Number: NCT03383562

Perioperative Electroacupuncture After Operation

Not Applicable

Conditions: Acupuncture
Gastrointestinal Function

Interventions: Procedure: Electroacupuncture
Procedure: Sham electroacupuncture

First Posted Date: 2017-09-25

Last Posted Date: 2017-09-25

Lead Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Target Recruit Count: 400

Registration Number: NCT03291561

Locations: 🇨🇳
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China

Perioperative Electroacupuncture for Gastric Cancer Patients After Gastrectomy

Not Applicable

Conditions: Acupuncture
Gastrointestinal Function

Interventions: Procedure: Electroacupuncture
Procedure: Sham electroacupuncture

First Posted Date: 2017-09-25

Last Posted Date: 2017-09-25

Lead Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Target Recruit Count: 400

Registration Number: NCT03291574

Locations: 🇨🇳
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China

A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）

Phase 3

Conditions: CYP2D6 Polymorphism

Interventions: Drug: Exemestane Tablets
Genetic: CYP2D6*10 gene test
Other: ovarian function suppression/ablation
Drug: Tamoxifen

First Posted Date: 2017-05-02

Last Posted Date: 2018-10-31

Lead Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Target Recruit Count: 300

Registration Number: NCT03137368

Locations: 🇨🇳
CancerIHCAMS, Beijing, Beijing, China

Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain

Phase 1

Conditions: Physicians
Oxycodone
Pain

Interventions: Device: APP software

First Posted Date: 2017-01-10

Last Posted Date: 2019-01-23

Lead Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Target Recruit Count: 200

Registration Number: NCT03016364

Locations: 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China

Translational Research on Locally Advanced Pancreatic Adenocarcinoma

Not Applicable

Conditions: Pancreatic Cancer

Interventions: Other: order of treatment

First Posted Date: 2017-01-04

Last Posted Date: 2017-01-04

Lead Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Target Recruit Count: 40

Registration Number: NCT03009253

Locations: 🇨🇳
Cancer Institute and Hospital ,China Academy of Medical Sciences, Beijing, Beijing, China

Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer

Not Applicable

Conditions: Lung Neoplasm

Interventions: Procedure: Three-port pulmonary resection surgery
Procedure: Single-port or two-port surgery

First Posted Date: 2016-12-14

Last Posted Date: 2016-12-14

Lead Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Target Recruit Count: 231

Registration Number: NCT02992353

Locations: 🇨🇳
Cancer Hospital of Chinese Academy of Medical Sciences, Beijing, Beijing, China

MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy

Not Applicable

Recruiting

Conditions: Esophagus Cancer
Esophagogastric Junction Cancer

Interventions: Device: MRI and CT
Radiation: Ratiotherapy
Drug: Paclitaxel, platinum-based drug

First Posted Date: 2016-12-12

Last Posted Date: 2023-11-24

Lead Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Target Recruit Count: 300

Registration Number: NCT02988921

Locations: 🇨🇳
Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy